# Pfizer Inc: financial statements, quarterly

PFE · NYSE · CIK 78003 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pfe.md) · [Financials](/companies/pfe/financials.md) · [Filings](/companies/pfe/filings.md) · [Insiders](/companies/pfe/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pfe/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [13.5](/filings/0000078003-24-000191.md) | [5.9 d](/filings/0000078003-24-000039.md) | [14.9](/filings/0000078003-25-000114.md) | [13.3](/filings/0000078003-25-000138.md) | [17.7](/filings/0000078003-25-000150.md) | [17.8 d](/filings/0000078003-26-000026.md) | [13.7](/filings/0000078003-26-000054.md) | [14.7](/filings/0000078003-26-000095.md) | [16.7](/filings/0000078003-25-000150.md) | [17.6 d](/filings/0000078003-26-000026.md) | [14.5](/filings/0000078003-26-000054.md) | [15.0](/filings/0000078003-26-000095.md) |
| Cost of revenue | $bn | [9.3](/filings/0000078003-24-000191.md) | [7.6 d](/filings/0000078003-26-000026.md) | [3.4](/filings/0000078003-25-000114.md) | [3.3](/filings/0000078003-25-000138.md) | [5.3](/filings/0000078003-25-000150.md) | [5.9 d](/filings/0000078003-26-000026.md) | [2.8](/filings/0000078003-26-000054.md) | [3.8](/filings/0000078003-26-000095.md) | [4.2](/filings/0000078003-25-000150.md) | [5.3 d](/filings/0000078003-26-000026.md) | [3.5](/filings/0000078003-26-000054.md) | [4.1](/filings/0000078003-26-000095.md) |
| Selling, general and administrative | $bn | [3.3](/filings/0000078003-24-000191.md) | [4.6 d](/filings/0000078003-26-000026.md) | [3.5](/filings/0000078003-25-000114.md) | [3.7](/filings/0000078003-25-000138.md) | [3.2](/filings/0000078003-25-000150.md) | [4.3 d](/filings/0000078003-26-000026.md) | [3.0](/filings/0000078003-26-000054.md) | [3.4](/filings/0000078003-26-000095.md) | [3.2](/filings/0000078003-25-000150.md) | [4.2 d](/filings/0000078003-26-000026.md) | [3.0](/filings/0000078003-26-000054.md) | [3.4](/filings/0000078003-26-000095.md) |
| Interest expense | $bn | [0.7](/filings/0000078003-24-000191.md) | [0.7 d](/filings/0000078003-26-000026.md) | [0.8](/filings/0000078003-25-000114.md) | [0.8](/filings/0000078003-25-000138.md) | [0.8](/filings/0000078003-25-000150.md) | [0.7 d](/filings/0000078003-26-000026.md) | [0.7](/filings/0000078003-26-000054.md) | [0.7](/filings/0000078003-26-000095.md) | [0.7](/filings/0000078003-25-000150.md) | [0.7 d](/filings/0000078003-26-000026.md) | [0.7](/filings/0000078003-26-000054.md) | [0.7](/filings/0000078003-26-000095.md) |
| Income tax | $bn | [(1.0)](/filings/0000078003-24-000191.md) | [(0.8) d](/filings/0000078003-26-000026.md) | [0.3](/filings/0000078003-25-000114.md) | [(0.1)](/filings/0000078003-25-000138.md) | [0.2](/filings/0000078003-25-000150.md) | [(0.4) d](/filings/0000078003-26-000026.md) | [(0.2)](/filings/0000078003-26-000054.md) | [0.1](/filings/0000078003-26-000095.md) | [(0.2)](/filings/0000078003-25-000150.md) | [(0.0) d](/filings/0000078003-26-000026.md) | [0.5](/filings/0000078003-26-000054.md) | [(0.4)](/filings/0000078003-26-000095.md) |
| Net income | $bn | [(2.4)](/filings/0000078003-24-000191.md) | [(3.4) d](/filings/0000078003-26-000026.md) | [3.1](/filings/0000078003-25-000114.md) | [0.0](/filings/0000078003-25-000138.md) | [4.5](/filings/0000078003-25-000150.md) | [0.4 d](/filings/0000078003-26-000026.md) | [3.0](/filings/0000078003-26-000054.md) | [2.9](/filings/0000078003-26-000095.md) | [3.5](/filings/0000078003-25-000150.md) | [(1.6) d](/filings/0000078003-26-000026.md) | [2.7](/filings/0000078003-26-000054.md) | [(0.2)](/filings/0000078003-26-000095.md) |
| Diluted EPS | $ per share | [(0.42)](/filings/0000078003-24-000191.md) | not reported | [0.55](/filings/0000078003-25-000114.md) | [0.01](/filings/0000078003-25-000138.md) | [0.78](/filings/0000078003-25-000150.md) | not reported | [0.52](/filings/0000078003-26-000054.md) | [0.51](/filings/0000078003-26-000095.md) | [0.62](/filings/0000078003-25-000150.md) | not reported | [0.47](/filings/0000078003-26-000054.md) | [(0.04)](/filings/0000078003-26-000095.md) |
| Basic EPS | $ per share | [(0.42)](/filings/0000078003-24-000191.md) | not reported | [0.55](/filings/0000078003-25-000114.md) | [0.01](/filings/0000078003-25-000138.md) | [0.79](/filings/0000078003-25-000150.md) | not reported | [0.52](/filings/0000078003-26-000054.md) | [0.51](/filings/0000078003-26-000095.md) | [0.62](/filings/0000078003-25-000150.md) | not reported | [0.47](/filings/0000078003-26-000054.md) | [(0.04)](/filings/0000078003-26-000095.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-01) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [3.1](/filings/0000078003-23-000115.md) | [2.9](/filings/0000078003-25-000054.md) | [0.7](/filings/0000078003-24-000107.md) | [1.1](/filings/0000078003-24-000166.md) | [1.1](/filings/0000078003-24-000191.md) | [1.0](/filings/0000078003-26-000026.md) | [1.4](/filings/0000078003-25-000114.md) | [1.6](/filings/0000078003-25-000138.md) | [1.3](/filings/0000078003-25-000150.md) | [1.1](/filings/0000078003-26-000095.md) | [1.7](/filings/0000078003-26-000054.md) | [1.0](/filings/0000078003-26-000095.md) |
| Current assets | $bn | [74.0](/filings/0000078003-23-000115.md) | [43.3](/filings/0000078003-25-000054.md) | [42.4](/filings/0000078003-24-000107.md) | [37.8](/filings/0000078003-24-000166.md) | [43.2](/filings/0000078003-24-000191.md) | [50.4](/filings/0000078003-26-000026.md) | [45.9](/filings/0000078003-25-000114.md) | [43.7](/filings/0000078003-25-000138.md) | [46.9](/filings/0000078003-25-000150.md) | [42.9](/filings/0000078003-26-000095.md) | [42.8](/filings/0000078003-26-000054.md) | [41.4](/filings/0000078003-26-000095.md) |
| Total assets | $bn | [215](/filings/0000078003-23-000115.md) | [227](/filings/0000078003-25-000054.md) | [221](/filings/0000078003-24-000107.md) | [216](/filings/0000078003-24-000166.md) | [219](/filings/0000078003-24-000191.md) | [213](/filings/0000078003-26-000026.md) | [208](/filings/0000078003-25-000114.md) | [206](/filings/0000078003-25-000138.md) | [209](/filings/0000078003-25-000150.md) | [208](/filings/0000078003-26-000095.md) | [208](/filings/0000078003-26-000054.md) | [201](/filings/0000078003-26-000095.md) |
| Current liabilities | $bn | [31.1](/filings/0000078003-23-000115.md) | [47.8](/filings/0000078003-25-000054.md) | [40.5](/filings/0000078003-24-000107.md) | [43.8](/filings/0000078003-24-000166.md) | [43.2](/filings/0000078003-24-000191.md) | [43.0](/filings/0000078003-26-000026.md) | [36.5](/filings/0000078003-25-000114.md) | [37.7](/filings/0000078003-25-000138.md) | [36.6](/filings/0000078003-25-000150.md) | [37.0](/filings/0000078003-26-000095.md) | [34.3](/filings/0000078003-26-000054.md) | [32.6](/filings/0000078003-26-000095.md) |
| Total liabilities | $bn | [118](/filings/0000078003-23-000115.md) | [137](/filings/0000078003-25-000054.md) | [129](/filings/0000078003-24-000107.md) | [128](/filings/0000078003-24-000166.md) | [127](/filings/0000078003-24-000191.md) | [125](/filings/0000078003-26-000026.md) | [117](/filings/0000078003-25-000114.md) | [117](/filings/0000078003-25-000138.md) | [116](/filings/0000078003-25-000150.md) | [121](/filings/0000078003-26-000095.md) | [117](/filings/0000078003-26-000054.md) | [116](/filings/0000078003-26-000095.md) |
| Long-term debt | $bn | [61.0](/filings/0000078003-23-000115.md) | [61.5](/filings/0000078003-25-000054.md) | [61.3](/filings/0000078003-24-000107.md) | [57.5](/filings/0000078003-24-000166.md) | [58.0](/filings/0000078003-24-000191.md) | [57.4](/filings/0000078003-26-000026.md) | [57.6](/filings/0000078003-25-000114.md) | [57.5](/filings/0000078003-25-000138.md) | [57.4](/filings/0000078003-25-000150.md) | [61.6](/filings/0000078003-26-000095.md) | [60.6](/filings/0000078003-26-000054.md) | [60.5](/filings/0000078003-26-000095.md) |
| Current portion of debt | $bn | [2.3](/filings/0000078003-23-000115.md) | [2.3](/filings/0000078003-25-000054.md) | [1.0](/filings/0000078003-24-000107.md) | [3.7](/filings/0000078003-24-000166.md) | [3.7](/filings/0000078003-24-000191.md) | [3.7](/filings/0000078003-26-000026.md) | [3.7](/filings/0000078003-25-000114.md) | [4.2](/filings/0000078003-25-000138.md) | [4.2](/filings/0000078003-25-000150.md) | [3.0](/filings/0000078003-26-000095.md) | [3.9](/filings/0000078003-26-000054.md) | [2.6](/filings/0000078003-26-000095.md) |
| Short-term borrowings | $bn | not reported | [8.0](/filings/0000078003-25-000054.md) | [6.9](/filings/0000078003-24-000107.md) | [8.0](/filings/0000078003-24-000166.md) | [5.8](/filings/0000078003-24-000191.md) | [2.5](/filings/0000078003-26-000026.md) | [0.2](/filings/0000078003-25-000114.md) | [0.0](/filings/0000078003-25-000138.md) | [0.0](/filings/0000078003-25-000150.md) | [0.0](/filings/0000078003-26-000026.md) | not reported | not reported |
| Shareholders' equity | $bn | [96.9](/filings/0000078003-23-000115.md) | [89.0](/filings/0000078003-25-000054.md) | [92.3](/filings/0000078003-24-000107.md) | [87.7](/filings/0000078003-24-000166.md) | [92.3](/filings/0000078003-24-000191.md) | [88.2](/filings/0000078003-26-000026.md) | [90.3](/filings/0000078003-25-000114.md) | [88.7](/filings/0000078003-25-000138.md) | [92.8](/filings/0000078003-25-000150.md) | [86.5](/filings/0000078003-26-000095.md) | [90.1](/filings/0000078003-26-000054.md) | [85.2](/filings/0000078003-26-000095.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-01) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [3,456 d](/filings/0000078003-24-000191.md) | [5,240 d](/filings/0000078003-26-000026.md) | [1,090](/filings/0000078003-25-000114.md) | [(1,781) d](/filings/0000078003-25-000138.md) | [6,714 d](/filings/0000078003-25-000150.md) | [6,721 d](/filings/0000078003-26-000026.md) | [2,335](/filings/0000078003-26-000054.md) | [(582) d](/filings/0000078003-26-000095.md) | [4,603 d](/filings/0000078003-25-000150.md) | [5,348 d](/filings/0000078003-26-000026.md) | [2,615](/filings/0000078003-26-000054.md) | [835 d](/filings/0000078003-26-000095.md) |
| Capital expenditure | $m | [810 d](/filings/0000078003-24-000191.md) | [1,044 d](/filings/0000078003-26-000026.md) | [704](/filings/0000078003-25-000114.md) | [637 d](/filings/0000078003-25-000138.md) | [651 d](/filings/0000078003-25-000150.md) | [917 d](/filings/0000078003-26-000026.md) | [564](/filings/0000078003-26-000054.md) | [618 d](/filings/0000078003-26-000095.md) | [602 d](/filings/0000078003-25-000150.md) | [845 d](/filings/0000078003-26-000026.md) | [436](/filings/0000078003-26-000054.md) | [533 d](/filings/0000078003-26-000095.md) |
| Share repurchases | $m | [0.0 d](/filings/0000078003-23-000115.md) | [0.0 d](/filings/0000078003-25-000054.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-02) | Q1 FY2023 (2023-04-02) | Q2 FY2023 (2023-07-02) | Q3 FY2023 (2023-10-01) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [5,718](/filings/0000078003-23-000115.md) | [5,727](/filings/0000078003-24-000107.md) | [5,713](/filings/0000078003-24-000166.md) | [5,646](/filings/0000078003-24-000191.md) | [5,697](/filings/0000078003-25-000114.md) | [5,696](/filings/0000078003-25-000138.md) | [5,705](/filings/0000078003-25-000150.md) | [5,710](/filings/0000078003-26-000054.md) | [5,706](/filings/0000078003-26-000095.md) | [5,714](/filings/0000078003-25-000150.md) | [5,731](/filings/0000078003-26-000054.md) | [5,699](/filings/0000078003-26-000095.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,699,673,589 at 2026-07-29, from the cover of the [10-Q filed 2026-08-04](/filings/0000078003-26-000095.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.